A recent study also showed that TINCR mediated regulation of PADI1-MAPK-MMP2/9 signaling pathway plays a key role in nasal pharyngeal cancer (NPC) progression and chemical resistance, suggesting that TINCR may be a therapeutic target for GC [160]. This evidence concerns the gene TINCR and nasopharyngeal carcinoma.